PI
TMO icon

PEAK6 Investments’s Thermo Fisher Scientific TMO Stock Holding History

PEAK6 Investments’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$20M Buy
32,300
+31,600
+4,514% +$18.7M 0.04% 340
2024
Q2 		$387K Sell
700
-4,700
-87% -$2.69M ﹤0.01% 2390
2024
Q1 		$3.14M Sell
5,400
-1,300
-19% -$729K 0.01% 1120
2023
Q4 		$3.56M Buy
6,700
+2,900
+76% +$1.4M 0.01% 1081
2023
Q3 		$1.92M Buy
3,800
+1,200
+46% +$639K 0.01% 1358
2023
Q2 		$1.36M Sell
2,600
-8,100
-76% -$4.37M 0.01% 1489
2023
Q1 		$6.17M Buy
10,700
+9,500
+792% +$5.35M 0.03% 604
2022
Q4 		$661K Sell
1,200
-10,700
-90% -$5.67M ﹤0.01% 2275
2022
Q3 		$6.04M Sell
11,900
-41,800
-78% -$23.4M 0.03% 721
2022
Q2 		$29.1M Buy
53,700
+39,800
+286% +$21.9M 0.06% 323
2022
Q1 		$8.21M Sell
13,900
-4,800
-26% -$2.76M 0.02% 798
2021
Q4 		$12.5M Sell
18,700
-6,600
-26% -$4.12M 0.03% 615
2021
Q3 		$14.5M Buy
25,300
+9,901
+64% +$5.43M 0.03% 518
2021
Q2 		$12.7M Buy
15,399
+7,699
+100% +$3.63M 0.03% 561
2021
Q1 		$3.52M Buy
7,700
+7,400
+2,467% +$3.53M 0.01% 1345
2020
Q4 		$140K Sell
300
-68,600
-100% -$32.2M ﹤0.01% 3898
2020
Q3 		$30.4M Buy
68,900
+33,300
+94% +$13.8M 0.08% 228
2020
Q2 		$12.9M Buy
35,600
+29,000
+439% +$9.72M 0.04% 391
2020
Q1 		$1.87M Buy
+6,600
New +$2.08M 0.01% 1068
2019
Q4 		– Sell
-800
Closed -$233K – 4067
2019
Q3 		$233K Sell
800
-11,100
-93% -$3.18M ﹤0.01% 2807
2019
Q2 		$3.5M Sell
11,900
-33,900
-74% -$9.34M 0.02% 919
2019
Q1 		$12.5M Sell
45,800
-4,100
-8% -$1.02M 0.07% 289
2018
Q4 		$11.2M Sell
49,900
-79,300
-61% -$18.6M 0.07% 305
2018
Q3 		$31.5M Buy
+129,200
New +$29.7M 0.14% 128

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PEAK6 Investments's TMO Position: Q3 2024 in Review

PEAK6 Investments reduced its Thermo Fisher Scientific (TMO) stake by 100% in Q3 2024, selling an estimated $2.52M and leaving 3 shares worth $1.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3315.

PEAK6 Investments first reported a position in TMO in Q4 2018 and has held it in 19 quarters since. The position peaked at $11.4M in Q4 2020. 2,569 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • PEAK6 Investments held 3 shares of Thermo Fisher Scientific worth $1.6K as of Q3 2024.
  • PEAK6 Investments sold 4,259 Thermo Fisher Scientific shares in Q3 2024, an estimated $2.52M.
  • Thermo Fisher Scientific made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3315 holding.
  • PEAK6 Investments first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 19 quarters since.
  • PEAK6 Investments's Thermo Fisher Scientific position peaked at $11.4M in Q4 2020.
  • 2,569 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.